Biographical Sketch
Mary P. Bronner, MD, is Director of Gastrointestinal Pathology and Section Head of Morphologic Molecular Pathology at Cleveland Clinic.
Her clinical interests include gastrointestinal, hepatic and pancreaticobiliary pathology and molecular diagnostics.
In 2005, she received the Purdy Stout Prize, recognizing her as a surgical pathologist under the age of 45 whose research publications have had a major impact on diagnostic pathology. She became part of the Elected Council of the United States and Canadian Academy of Pathology in 2007.
Dr. Bronner received her medical degree in 1989 from University of Pennsylvania School of Medicine, Philadelphia, Penn., where she also completed her residency.
Specialty Interests
gastrointestinal, hepatic and pancreaticobiliary pathology and molecular diagnostics
Innovations & Patents
Patent Pending for Discovery of Palladin as the Gene for Non-Syndromic Hereditary Pancreatic Cancer
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 8/6/2008,
Dr. Bronner has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
